President Trump reverses Biden's order to cap out-of-pocket costs for prescription drugs, potentially increasing costs for Medicare and Medicaid recipients.
The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...
Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.